Characteristics of Choroidal Neovascularization in the Complications of Age-Related Macular Degeneration Prevention Trial
Objective To describe the characteristics of incident choroidal neovascularization (CNV) in observed and treated eyes in the Complications of Age-related Macular Degeneration Prevention Trial (CAPT). Design Cross-sectional descriptive study within a multicenter, randomized clinical trial. Participan...
Gespeichert in:
Veröffentlicht in: | Ophthalmology (Rochester, Minn.) Minn.), 2008-09, Vol.115 (9), p.1468-1473.e2 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1473.e2 |
---|---|
container_issue | 9 |
container_start_page | 1468 |
container_title | Ophthalmology (Rochester, Minn.) |
container_volume | 115 |
creator | Maguire, Maureen G., PhD Alexander, Judith Fine, Stuart L., MD |
description | Objective To describe the characteristics of incident choroidal neovascularization (CNV) in observed and treated eyes in the Complications of Age-related Macular Degeneration Prevention Trial (CAPT). Design Cross-sectional descriptive study within a multicenter, randomized clinical trial. Participants Patients who developed CNV during CAPT follow-up. Methods Inclusion criteria for CAPT specified bilateral large drusen (≥10 drusen at least 125 μ), visual acuity ≥20/40 in each eye, and age ≥50. Exclusion criteria included CNV and geographic atrophy >1 Macular Photocoagulation Study (MPS) disc area or within 500 μ of the foveal center. One eye of each person was selected randomly for low-intensity laser treatment and the contralateral eye was observed. Fluorescein angiography was performed at baseline, annually for ≥5 years, and whenever there were symptoms of CNV. Trained readers at the CAPT Photograph Reading Center assessed color stereo photographs and angiogram negatives to identify CNV. Main Outcome Measures Choroidal neovascularization was classified by type (predominantly classic CNV, minimally classic CNV, occult only CNV, or scar), location, and area. Visual acuity was measured by certified examiners. Symmetry of characteristics between eyes of bilaterally affected patients was examined. Results Choroidal neovascularization developed in 282 eyes of 225 patients. At the time of detection, 192 (68%) of the lesions were occult only, 153 (54%) were subfoveal, and 157 (56%) were ≤2 MPS disc areas. Visual acuity was ≥20/40 in 123 (69%) of 179 eyes with visual acuity measured at the time of detection. Choroidal neovascularization developed in both eyes in 57 patients (25%) during CAPT follow-up. Lesions in eyes of bilaterally affected patients were no more similar to each other than affected eyes in 2 different patients. Conclusions When patients are monitored closely, many CNV lesions can be detected outside of the fovea and when they are relatively small. Early detection may lead to improved long-term visual acuity. Financial Disclosure(s) The authors have no proprietary or commercial interest in any materials discussed in this article. |
doi_str_mv | 10.1016/j.ophtha.2008.02.028 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69496053</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0161642008002224</els_id><sourcerecordid>69496053</sourcerecordid><originalsourceid>FETCH-LOGICAL-c445t-ae54965a47c959d207a1651adc19739cfae04bd3814b26e29440f7217fe86d943</originalsourceid><addsrcrecordid>eNqFkl-L1DAUxYMo7rj6DUT6om8dkzRN0xdhqborrH_Q9TncSW-3GTPNmLQD46c3nQ4KvggXEsI5Jze_XEKeM7pmlMnX27Xf92MPa06pWlOeSj0gK1aKOhcVKx6SVZKxXApOL8iTGLeUUikL8ZhcMCWU5JyvyLHpIYAZMdg4WhMz32VN74O3LbjsE_oDRDM5CPYXjNYPmR2ysces8bu9s-Z0djJd3WP-FR2M2GYf4WTJ3uI9DhgW45eABxxO27tgwT0ljzpwEZ-d10vy_f27u-Ymv_18_aG5us2NEOWYA6YHyRJEZeqybjmtgMmSQWtYXRW16QCp2LSFYmLDJfJaCNpVnFUdKtnWorgkr5bcffA_J4yj3tlo0DkY0E9Ryzrl07JIQrEITfAxBuz0PtgdhKNmVM_I9VYvyPWMXFOeSiXbi3P-tNlh-9d0ZpwEL8-ChBJcF2AwNv7RcSqZKtR8_5tFh4nGwWLQ0VgcDLY2oBl16-3_Ovk3wDg7pE9yP_CIceunMCTSmumYDPrbPB7zdFBFaWpUFL8Bbii3Xw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69496053</pqid></control><display><type>article</type><title>Characteristics of Choroidal Neovascularization in the Complications of Age-Related Macular Degeneration Prevention Trial</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Maguire, Maureen G., PhD ; Alexander, Judith ; Fine, Stuart L., MD</creator><creatorcontrib>Maguire, Maureen G., PhD ; Alexander, Judith ; Fine, Stuart L., MD ; Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group</creatorcontrib><description>Objective To describe the characteristics of incident choroidal neovascularization (CNV) in observed and treated eyes in the Complications of Age-related Macular Degeneration Prevention Trial (CAPT). Design Cross-sectional descriptive study within a multicenter, randomized clinical trial. Participants Patients who developed CNV during CAPT follow-up. Methods Inclusion criteria for CAPT specified bilateral large drusen (≥10 drusen at least 125 μ), visual acuity ≥20/40 in each eye, and age ≥50. Exclusion criteria included CNV and geographic atrophy >1 Macular Photocoagulation Study (MPS) disc area or within 500 μ of the foveal center. One eye of each person was selected randomly for low-intensity laser treatment and the contralateral eye was observed. Fluorescein angiography was performed at baseline, annually for ≥5 years, and whenever there were symptoms of CNV. Trained readers at the CAPT Photograph Reading Center assessed color stereo photographs and angiogram negatives to identify CNV. Main Outcome Measures Choroidal neovascularization was classified by type (predominantly classic CNV, minimally classic CNV, occult only CNV, or scar), location, and area. Visual acuity was measured by certified examiners. Symmetry of characteristics between eyes of bilaterally affected patients was examined. Results Choroidal neovascularization developed in 282 eyes of 225 patients. At the time of detection, 192 (68%) of the lesions were occult only, 153 (54%) were subfoveal, and 157 (56%) were ≤2 MPS disc areas. Visual acuity was ≥20/40 in 123 (69%) of 179 eyes with visual acuity measured at the time of detection. Choroidal neovascularization developed in both eyes in 57 patients (25%) during CAPT follow-up. Lesions in eyes of bilaterally affected patients were no more similar to each other than affected eyes in 2 different patients. Conclusions When patients are monitored closely, many CNV lesions can be detected outside of the fovea and when they are relatively small. Early detection may lead to improved long-term visual acuity. Financial Disclosure(s) The authors have no proprietary or commercial interest in any materials discussed in this article.</description><identifier>ISSN: 0161-6420</identifier><identifier>EISSN: 1549-4713</identifier><identifier>DOI: 10.1016/j.ophtha.2008.02.028</identifier><identifier>PMID: 18486222</identifier><identifier>CODEN: OPHTDG</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Biological and medical sciences ; Choroidal Neovascularization - classification ; Choroidal Neovascularization - diagnosis ; Choroidal Neovascularization - etiology ; Choroidal Neovascularization - prevention & control ; Cross-Sectional Studies ; Fluorescein Angiography ; Follow-Up Studies ; Humans ; Laser Coagulation ; Macular Degeneration - complications ; Medical sciences ; Miscellaneous ; Ophthalmology ; Photography ; Reproducibility of Results ; Retinopathies ; Visual Acuity</subject><ispartof>Ophthalmology (Rochester, Minn.), 2008-09, Vol.115 (9), p.1468-1473.e2</ispartof><rights>American Academy of Ophthalmology</rights><rights>2008 American Academy of Ophthalmology</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c445t-ae54965a47c959d207a1651adc19739cfae04bd3814b26e29440f7217fe86d943</citedby><cites>FETCH-LOGICAL-c445t-ae54965a47c959d207a1651adc19739cfae04bd3814b26e29440f7217fe86d943</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0161642008002224$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20618383$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18486222$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Maguire, Maureen G., PhD</creatorcontrib><creatorcontrib>Alexander, Judith</creatorcontrib><creatorcontrib>Fine, Stuart L., MD</creatorcontrib><creatorcontrib>Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group</creatorcontrib><title>Characteristics of Choroidal Neovascularization in the Complications of Age-Related Macular Degeneration Prevention Trial</title><title>Ophthalmology (Rochester, Minn.)</title><addtitle>Ophthalmology</addtitle><description>Objective To describe the characteristics of incident choroidal neovascularization (CNV) in observed and treated eyes in the Complications of Age-related Macular Degeneration Prevention Trial (CAPT). Design Cross-sectional descriptive study within a multicenter, randomized clinical trial. Participants Patients who developed CNV during CAPT follow-up. Methods Inclusion criteria for CAPT specified bilateral large drusen (≥10 drusen at least 125 μ), visual acuity ≥20/40 in each eye, and age ≥50. Exclusion criteria included CNV and geographic atrophy >1 Macular Photocoagulation Study (MPS) disc area or within 500 μ of the foveal center. One eye of each person was selected randomly for low-intensity laser treatment and the contralateral eye was observed. Fluorescein angiography was performed at baseline, annually for ≥5 years, and whenever there were symptoms of CNV. Trained readers at the CAPT Photograph Reading Center assessed color stereo photographs and angiogram negatives to identify CNV. Main Outcome Measures Choroidal neovascularization was classified by type (predominantly classic CNV, minimally classic CNV, occult only CNV, or scar), location, and area. Visual acuity was measured by certified examiners. Symmetry of characteristics between eyes of bilaterally affected patients was examined. Results Choroidal neovascularization developed in 282 eyes of 225 patients. At the time of detection, 192 (68%) of the lesions were occult only, 153 (54%) were subfoveal, and 157 (56%) were ≤2 MPS disc areas. Visual acuity was ≥20/40 in 123 (69%) of 179 eyes with visual acuity measured at the time of detection. Choroidal neovascularization developed in both eyes in 57 patients (25%) during CAPT follow-up. Lesions in eyes of bilaterally affected patients were no more similar to each other than affected eyes in 2 different patients. Conclusions When patients are monitored closely, many CNV lesions can be detected outside of the fovea and when they are relatively small. Early detection may lead to improved long-term visual acuity. Financial Disclosure(s) The authors have no proprietary or commercial interest in any materials discussed in this article.</description><subject>Biological and medical sciences</subject><subject>Choroidal Neovascularization - classification</subject><subject>Choroidal Neovascularization - diagnosis</subject><subject>Choroidal Neovascularization - etiology</subject><subject>Choroidal Neovascularization - prevention & control</subject><subject>Cross-Sectional Studies</subject><subject>Fluorescein Angiography</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Laser Coagulation</subject><subject>Macular Degeneration - complications</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Ophthalmology</subject><subject>Photography</subject><subject>Reproducibility of Results</subject><subject>Retinopathies</subject><subject>Visual Acuity</subject><issn>0161-6420</issn><issn>1549-4713</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkl-L1DAUxYMo7rj6DUT6om8dkzRN0xdhqborrH_Q9TncSW-3GTPNmLQD46c3nQ4KvggXEsI5Jze_XEKeM7pmlMnX27Xf92MPa06pWlOeSj0gK1aKOhcVKx6SVZKxXApOL8iTGLeUUikL8ZhcMCWU5JyvyLHpIYAZMdg4WhMz32VN74O3LbjsE_oDRDM5CPYXjNYPmR2ysces8bu9s-Z0djJd3WP-FR2M2GYf4WTJ3uI9DhgW45eABxxO27tgwT0ljzpwEZ-d10vy_f27u-Ymv_18_aG5us2NEOWYA6YHyRJEZeqybjmtgMmSQWtYXRW16QCp2LSFYmLDJfJaCNpVnFUdKtnWorgkr5bcffA_J4yj3tlo0DkY0E9Ryzrl07JIQrEITfAxBuz0PtgdhKNmVM_I9VYvyPWMXFOeSiXbi3P-tNlh-9d0ZpwEL8-ChBJcF2AwNv7RcSqZKtR8_5tFh4nGwWLQ0VgcDLY2oBl16-3_Ovk3wDg7pE9yP_CIceunMCTSmumYDPrbPB7zdFBFaWpUFL8Bbii3Xw</recordid><startdate>20080901</startdate><enddate>20080901</enddate><creator>Maguire, Maureen G., PhD</creator><creator>Alexander, Judith</creator><creator>Fine, Stuart L., MD</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20080901</creationdate><title>Characteristics of Choroidal Neovascularization in the Complications of Age-Related Macular Degeneration Prevention Trial</title><author>Maguire, Maureen G., PhD ; Alexander, Judith ; Fine, Stuart L., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c445t-ae54965a47c959d207a1651adc19739cfae04bd3814b26e29440f7217fe86d943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Biological and medical sciences</topic><topic>Choroidal Neovascularization - classification</topic><topic>Choroidal Neovascularization - diagnosis</topic><topic>Choroidal Neovascularization - etiology</topic><topic>Choroidal Neovascularization - prevention & control</topic><topic>Cross-Sectional Studies</topic><topic>Fluorescein Angiography</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Laser Coagulation</topic><topic>Macular Degeneration - complications</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Ophthalmology</topic><topic>Photography</topic><topic>Reproducibility of Results</topic><topic>Retinopathies</topic><topic>Visual Acuity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Maguire, Maureen G., PhD</creatorcontrib><creatorcontrib>Alexander, Judith</creatorcontrib><creatorcontrib>Fine, Stuart L., MD</creatorcontrib><creatorcontrib>Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Ophthalmology (Rochester, Minn.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Maguire, Maureen G., PhD</au><au>Alexander, Judith</au><au>Fine, Stuart L., MD</au><aucorp>Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characteristics of Choroidal Neovascularization in the Complications of Age-Related Macular Degeneration Prevention Trial</atitle><jtitle>Ophthalmology (Rochester, Minn.)</jtitle><addtitle>Ophthalmology</addtitle><date>2008-09-01</date><risdate>2008</risdate><volume>115</volume><issue>9</issue><spage>1468</spage><epage>1473.e2</epage><pages>1468-1473.e2</pages><issn>0161-6420</issn><eissn>1549-4713</eissn><coden>OPHTDG</coden><abstract>Objective To describe the characteristics of incident choroidal neovascularization (CNV) in observed and treated eyes in the Complications of Age-related Macular Degeneration Prevention Trial (CAPT). Design Cross-sectional descriptive study within a multicenter, randomized clinical trial. Participants Patients who developed CNV during CAPT follow-up. Methods Inclusion criteria for CAPT specified bilateral large drusen (≥10 drusen at least 125 μ), visual acuity ≥20/40 in each eye, and age ≥50. Exclusion criteria included CNV and geographic atrophy >1 Macular Photocoagulation Study (MPS) disc area or within 500 μ of the foveal center. One eye of each person was selected randomly for low-intensity laser treatment and the contralateral eye was observed. Fluorescein angiography was performed at baseline, annually for ≥5 years, and whenever there were symptoms of CNV. Trained readers at the CAPT Photograph Reading Center assessed color stereo photographs and angiogram negatives to identify CNV. Main Outcome Measures Choroidal neovascularization was classified by type (predominantly classic CNV, minimally classic CNV, occult only CNV, or scar), location, and area. Visual acuity was measured by certified examiners. Symmetry of characteristics between eyes of bilaterally affected patients was examined. Results Choroidal neovascularization developed in 282 eyes of 225 patients. At the time of detection, 192 (68%) of the lesions were occult only, 153 (54%) were subfoveal, and 157 (56%) were ≤2 MPS disc areas. Visual acuity was ≥20/40 in 123 (69%) of 179 eyes with visual acuity measured at the time of detection. Choroidal neovascularization developed in both eyes in 57 patients (25%) during CAPT follow-up. Lesions in eyes of bilaterally affected patients were no more similar to each other than affected eyes in 2 different patients. Conclusions When patients are monitored closely, many CNV lesions can be detected outside of the fovea and when they are relatively small. Early detection may lead to improved long-term visual acuity. Financial Disclosure(s) The authors have no proprietary or commercial interest in any materials discussed in this article.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>18486222</pmid><doi>10.1016/j.ophtha.2008.02.028</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0161-6420 |
ispartof | Ophthalmology (Rochester, Minn.), 2008-09, Vol.115 (9), p.1468-1473.e2 |
issn | 0161-6420 1549-4713 |
language | eng |
recordid | cdi_proquest_miscellaneous_69496053 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Biological and medical sciences Choroidal Neovascularization - classification Choroidal Neovascularization - diagnosis Choroidal Neovascularization - etiology Choroidal Neovascularization - prevention & control Cross-Sectional Studies Fluorescein Angiography Follow-Up Studies Humans Laser Coagulation Macular Degeneration - complications Medical sciences Miscellaneous Ophthalmology Photography Reproducibility of Results Retinopathies Visual Acuity |
title | Characteristics of Choroidal Neovascularization in the Complications of Age-Related Macular Degeneration Prevention Trial |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T04%3A36%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characteristics%20of%20Choroidal%20Neovascularization%20in%20the%20Complications%20of%20Age-Related%20Macular%20Degeneration%20Prevention%20Trial&rft.jtitle=Ophthalmology%20(Rochester,%20Minn.)&rft.au=Maguire,%20Maureen%20G.,%20PhD&rft.aucorp=Complications%20of%20Age-related%20Macular%20Degeneration%20Prevention%20Trial%20(CAPT)%20Research%20Group&rft.date=2008-09-01&rft.volume=115&rft.issue=9&rft.spage=1468&rft.epage=1473.e2&rft.pages=1468-1473.e2&rft.issn=0161-6420&rft.eissn=1549-4713&rft.coden=OPHTDG&rft_id=info:doi/10.1016/j.ophtha.2008.02.028&rft_dat=%3Cproquest_cross%3E69496053%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69496053&rft_id=info:pmid/18486222&rft_els_id=1_s2_0_S0161642008002224&rfr_iscdi=true |